Genetics News

KRAKÓW, Poland--(BUSINESS WIRE)--intoDNA announces that it will present two posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting....

NEW YORK--(BUSINESS WIRE)--Volastra Therapeutics, a clinical-stage oncology company pioneering therapies targeting chromosomal instability (CIN), today announced multiple scientific disclosures coinciding with the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17–22 in San Diego, California. The data define an Rb pathway–driven pan-cancer development framework for KIF18A inhibitors and highlight a proprietary p16 IHC biomarker approach designed to transl...

ALBANY, N.Y. & SHANGHAI--(BUSINESS WIRE)--Drug Farm today announced that preliminary immunologic and clinical results from its Phase 1b study of DF-003, a first-in-class oral ALPK1 inhibitor, will be presented in a podium session at IMMUNOLOGY2026, taking place April 15–19, 2026, in Boston, Massachusetts. The presentation will highlight early evidence of clinical benefit and pharmacodynamic improvement in patients with ROSAH syndrome, a rare genetic autoinflammatory disease driven by disease-ca...

NIJMEGEN, The Netherlands--(BUSINESS WIRE)--Khondrion announced that the first patient has been dosed in the Phase 3 study evaluating sonlicromanol in m.3243A>G Primary Mitochondrial Disease....

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on April 15, 2026, it granted stock options to purchase an aggregate of 129,565 shares of common stock to fourt...

SYDNEY--(BUSINESS WIRE)--Inventia Life Science today announced the launch of RASTRUM™ Validated Solutions, a new product offering designed to help drug discovery teams generate decision-grade data from human-relevant 3D cell models with greater speed, confidence, and reproducibility. Powered by the RASTRUM platform, Validated Solutions provide predefined model blueprints for reproducible, biologically relevant 3D data in a defined context of use. Validated Solutions are part of Inventia Life Sc...

SAN JOSE, Calif.--(BUSINESS WIRE)--Takara Bio USA, Inc. today announced the launch of its CSP Program and announced the certification of Admera Health on the Shasta® system....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK) today announced that it will report first quarter 2026 financial results on Thursday, May 7, 2026, before the financial markets open. The Company will host a conference call and webcast with Scholar Rock management at 8:00 a.m. ET. To access the live audio webcast, please go to “Events and Presentations” in the Investors section of the Scholar Rock website at http://investors.scholarrock.com. To participate via telephone, please reg...

BOSTON--(BUSINESS WIRE)--Delve Bio announces data showing Delve Detect enables neurologists to treat CNS infections when conventional testing fails at AAN Annual Meeting...

MADISON, Wis.--(BUSINESS WIRE)--Promega presents bioluminescence tools, MSI companion diagnostics, and automated sample prep protocols at AACR Annual Meeting 2026....